Release Date: 26/07/18 08:30 Summary: REVA Enters Peripheral Artery Disease Space with MOTIV Price Sensitive: Yes Download Document 53.21KB Download
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
